Recent studies have been exploring a growing trend in combining immune checkpoint inhibitors with small-molecule inhibitors targeting different pathways. Currently, inhibitors are directed at molecules like EGFR, VEGFR, PI3K, MAPK pathway, STING, TLR, and ALK. This approach has shown promising tumor responses in selected patients. Learn more: https://immune-checkpoint.creative-biolabs.com/immune-checkpoint-therapy.htm
"Great ideas, research and innovation can come from anyone – so often the best ideas do not have a voice. IdeaSpies provides a platform for people to share ideas that create a better world"
Jonathan Chrimes
IdeaSpies